 |
市場調查報告書
商品編碼
1671380
切片檢查設備市場：全球產品、技術、最終用戶和地區 - 預測至 2030 年Biopsy Devices Market by Product (Core needle biopsy (Automatic, Disposable)), Technology (Ultrasound,stereotactic), Application (Oncology, Gastroenterology, Bone & Bone marrow biopsy), End User (Diagnostic imaging centres) - Global Forecast to 2030 |
||||||
價格
全球切片檢查設備市場預計將從 2024 年的 72.7 億美元成長到 2030 年的 110.1 億美元，預測期內的複合年成長率為 7.2%。
| 研究範圍 | |
|---|---|
| 調查年份 | 2024-2030 |
| 基準年 | 2023 |
| 預測期 | 2024-2030 |
| 考慮單位 | 金額（十億美元） |
| 部分 | 按產品、技術、最終用戶、地區 |
| 目標區域 | 北美、歐洲、亞太地區、拉丁美洲、中東和非洲、海灣合作理事會國家 |
其中最大的促進因素之一是癌症發生率的不斷上升，尤其是乳癌、肺癌和攝護腺癌，這些癌症需要準確、早期的診斷檢測。世界衛生組織（WHO）預測，到2030年癌症患者數量可能還會大幅增加。因此，對切片檢查設備的需求預計會增加。此外，對微創手術的需求不斷成長，進一步推動了市場成長。真空輔助切片檢查和液體切片檢查等較新的切片檢查方法更準確，恢復時間更短，並能減輕患者的不適。此外，機器人輔助切片檢查設備、基於人工智慧的診斷系統和影像引導切片檢查技術等技術進步將提高準確性和效率，進一步推動市場成長。此外，政府加大癌症篩檢計畫力度，以及醫療保健支出不斷增加（尤其是在新興國家），正在推動市場向前發展。然而，先進的切片檢查設備的高成本和嚴格的法規環境可能會成為限制因素。
根據產品，切片檢查設備市場分為針吸活體組織切片設備、視覺化設備、刷切片檢查設備、切片檢查配件和機器人切片檢查設備。其中，針吸活體組織切片設備部分將成為切片檢查設備市場中成長最快的部分，到 2023 年將佔據 7.8% 的市場佔有率。這是因為人們越來越偏好使用微創診斷干預。針吸活體組織切片設備，例如粗針穿刺切片( CNB)、細針抽吸切片檢查(VAB)，是切片檢查切片檢查侵入性更小、痛苦更小的替代方法。這減少了患者的痛苦、恢復時間和手術成本。此外，人們對疾病早期發現和精準醫療的日益關注也推動了對針刺活體組織切片的需求，針刺活體組織切片可以提供高度精確的組織樣本並且併發症更少。此外，由於針刺活體組織切片速度快且對基礎設施要求不高，因此向門診/門診設施進行切片檢查的趨勢也在擴大市場。然而，出血、感染和取樣錯誤的風險對該市場的成長構成了挑戰。
根據應用，切片檢查設備市場分為腫瘤學、胃腸道、骨骼和骨髓切片檢查等。胃腸道領域在切片檢查設備市場中佔有第二大市場佔有率。這是由於胃腸道（GI）疾病病例的增加和切片檢查技術的進步。此外，結腸癌、胃癌、發炎性腸道疾病疾病(IBD)、乳糜感染疾病和胃腸道感染等胃腸道疾病需要切片檢查才能正確診斷。此外，大腸直腸癌是世界上復發率最高的癌症之一，其發生率不斷上升是導致胃腸道切片檢查設備需求增加的主要原因。此外，影像引導切片檢查，即超音波超音波引導下細針抽吸（EUS-FNA）和細針活體組織切片（EUS-FNB）的使用日益增多，提高了診斷深層胃腸道腫瘤的準確性，從而促進了市場的成長。此外，患有胃腸道疾病的老年人口的增加和全球醫療保健基礎設施的進步也推動了市場的成長。
本報告研究了全球切片檢查設備市場，按產品、技術、最終用戶和地區進行細分，並提供了參與市場的公司概況。
目錄
第 1 章 簡介
第2章調查方法
第3章執行摘要
第 4 章重要考察
第5章 市場概況
- 介紹
- 市場動態
- 產業趨勢
- 技術分析
- 波特五力分析
- 監管狀態
- 專利分析
- 貿易分析
- 定價分析
- 重要會議及活動
- 主要相關人員和採購標準
- 切片檢查設備市場：未滿足的最終用戶需求/期望
- 生態系分析
- 案例研究分析
- 供應鏈分析
- 鄰近市場分析
- 影響客戶業務的趨勢/中斷
- 投資金籌措場景
- 人工智慧對切片檢查設備市場的影響
第6章切片檢查設備市場（按產品）
- 介紹
- 針吸切片裝置
- 可視化設備/系統
- 刷切片檢查切片裝置
- 切片檢查配件
- 機器人切片檢查裝置
第 7 章切片檢查設備市場（按技術）
- 介紹
- 超音波引導下切片檢查
- 立體定位切片檢查
- 其他
第 8 章切片檢查設備市場（按應用）
- 介紹
- 腫瘤學
- 胃腸病學
- 骨和骨髓切片檢查
- 其他
第 9 章切片檢查設備市場（按最終用戶）
- 介紹
- 醫院及乳房護理中心
- 診斷影像中心
- 門診手術中心
- 其他
第 10 章切片檢查設備市場（按地區）
- 介紹
- 北美洲
- 宏觀經濟展望
- 美國
- 加拿大
- 歐洲
- 宏觀經濟展望
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 其他
- 亞太地區
- 宏觀經濟展望
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 其他
- 拉丁美洲
- 宏觀經濟展望
- 巴西
- 墨西哥
- 其他
- 中東和非洲
- 宏觀經濟展望
- 海灣合作理事會國家
- 其他
第11章 競爭格局
- 概述
- 主要參與企業的策略/優勢
- 收益分析
- 市場佔有率分析
- 公司估值矩陣：主要參與企業，2023 年
- 公司估值矩陣：Start-Ups/中小企業，2023 年
- 估值及財務指標
- 品牌/產品比較
- 競爭場景
第12章 公司簡介
- 主要參與企業
- BD（BECTON, DICKINSON AND COMPANY）
- DEVICOR MEDICAL PRODUCTS, INC
- MEDTRONIC
- CARDINAL HEALTH
- HOLOGIC, INC.
- B. BRAUN SE
- OLYMPUS CORPORATION
- BOSTON SCIENTIFIC CORPORATION
- FUJIFILM CORPORATION
- STRYKER
- TELEFLEX INCORPORATED
- CONMED CORPORATION
- MERIT MEDICAL SYSTEMS
- JOHNSON & JOHNSON SERVICES, INC.
- COOK GROUP
- 其他公司
- MICROPORT SCIENTIFIC CORPORATION
- ARGON MEDICAL DEVICES
- INRAD, INC.
- SUMMIT MEDICAL LLC
- TRANSMED7, LLC
- DR. JAPAN CO., LTD.
- IZI MEDICAL PRODUCTS
- PLANMED OY
- ADVIN HEALTH CARE
- TRIVITRON HEALTHCARE
第13章 附錄
Product Code: BT 5504
The global biopsy device market is projected to reach USD 11.01 billion by 2030 from USD 7.27 billion in 2024, at a CAGR of 7.2% during the forecast period."
| Scope of the Report | |
|---|---|
| Years Considered for the Study | 2024-2030 |
| Base Year | 2023 |
| Forecast Period | 2024-2030 |
| Units Considered | Value (USD Billion) |
| Segments | Product, Technology, Application, End User, and Region |
| Regions covered | North America, Europe, Asia Pacific, Latin America, the Middle East & Africa and GCC Countries |
One of the biggest drivers is the growing incidence of cancer, especially breast, lung, and prostate cancers, which need precise and early diagnostic tests. The World Health Organization states that cancer cases are likely to increase substantially by 2030. Therefore, there would be an increasing demand for biopsy devices. Also, the growing demand for less invasive procedures is driving market growth further. The newer biopsy methods like vacuum-assisted and liquid biopsies are more accurate, have lower recovery times, and cause lower patient discomfort Furthermore, advances in technology, such as robotic-assisted biopsy machines, AI-based diagnostic systems, and image-guided biopsy procedures, improve accuracy and efficiency, driving market growth further. Moreover, rising government programs for cancer screening, combined with rising healthcare spending, especially in developing nations, drive the market forward. Nonetheless, the high prices of sophisticated biopsy devices and strict regulatory environments can serve as constraints.
"The needle-based biopsy instrument segment to grow the fastest during the forecast period."
Based on the product, the biopsy device market is divided into Needle-based biopsy instrument, Visualization device, Brush biopsy instrument, Biopsy accessory and Robotic biopsy device. Among these, in 2023, Needle-based biopsy instrument segment account for the highest growing segment of 7.8% in biopsy device market. This is due to rising preference for the utilization of minimally invasive diagnostic interventions. The Needle biopsy devices such as core needle biopsy (CNB), fine needle aspiration biopsy (FNAB), and vacuum-assisted biopsy (VAB) devices provide a less painful and less invasive alternative to surgical biopsies. This lowers patient pain, recovery time, and procedural expenses. Moreover, the growing focus on early disease detection and precision medicine has also driven demand for needle biopsies, as they yield very accurate tissue samples with few complications. Further, the increasing trend towards ambulatory and outpatient facilities for biopsies has also increased the market, as needle biopsies are quick and require little infrastructure. However, the risks of bleeding, infection, and sampling errors pose challenges to the growth of this market.
"The gastroenterology segment accounts for the second largest market share in biopsy device market."
Based on application, the biopsy device market is segmented into oncology, Gastroenterology, Bone & Bone marrow biopsy and other applications. The gastroenterology segment accounts for the second largest market share in biopsy device market. This can be attributed to the growing cased of gastrointestinal (GI) diseases and technological advancements in endoscopic biopsy methods. Moreover, the GI disorders such as Colorectal cancer, gastric cancer, inflammatory bowel disease (IBD), celiac disease, and gastrointestinal infections need biopsy procedures for proper diagnosis. Further, the increasing incidence of colorectal cancer, one of the most recurrently diagnosed cancers globally, makes a major contribution to the need for GI biopsy devices. Furthermore, the growing use of image-guided biopsy methods, namely endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) and fine-needle biopsy (EUS-FNB), improves diagnostic accuracy in deep-seated GI tumors, contributing to market growth. Moreover, rise in geriatric population suffering from GI disorders and advancements in healthcare infrastructure on a worldwide level favour market growth.
"Asia Pacific accounted for the fastest growing of the biopsy device market by region."
The global biopsy device market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Asia Pacific is the fastest growing regional market for the biopsy device and is estimated to grow at the highest CAGR during the forecast period. The increasing incidence of cancer, coupled by demographic changes and lifestyle factors, has increased the need for early diagnosis, driving the use of biopsy procedures. Development of healthcare infrastructure, especially in nations such as China, India, and Japan, has increased access to sophisticated diagnostic technologies. Further, government initiatives and rising healthcare expenditures have also aided cancer screening programs, stimulating market growth. Moreover, the growing medical tourism industry in the region, specifically in countries with low-cost yet high-quality biopsy services, has also increased the growth in demand.
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier 1-45%, Tier 2-30%, and Tier 3- 25%
- By Designation: C-level-35%, Director-level-25% and Others-40%
- By Region: North America-40%, Europe-20%, Asia Pacific-25%, Latin America- 10%, and Middle east and Africa-5%
Note 1: Note: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.
Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs.
Note 3: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
The major players operating in the biopsy device market are BD (US), Devicor medical products, Inc (US), Medtronic (Ireland), Cardinal Health (US), B.Braun SE ( Germany), Hologic,Inc (US), Olympus Corporation (Japan), Boston Scientific Corporation (US), FUJIFILM Corporation (Japan), Stryker (US), Teleflex Incorporated (US), CONMED Corporation (US), Merit Medical Systems (US), Johnson & Johnson Services,Inc. (US), Cook Group (US), MicroPort Scientific Corporation (China), Argon Medical Devices (US), INRAD, Inc (US), Summit Medical LLC (US), TransMed7, LLC (US), Dr. Japan Co., Ltd. (Japan), IZI Medical Products (US), Planmed Oy (Finland), Advin Health Care (India), Trivitron Healthcare (India).
Research Coverage
This report studies the biopsy device market based on product, type, technology, application end user and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.
This report provides insights on the following pointers:
- Analysis of Key divers (Rising prevalence of cancer), restraints (Increasing product recalls), Challenge (Technological advancements), opportunity (Underdeveloped healthcare infrastructure in emerging economies)
- Market Penetration: Comprehensive information on the product portfolios offered by the top players in the bbiopsy device market
- Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the biopsy device market
- Market Development: Comprehensive information on lucrative emerging regions
- Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the biopsy devices market
- Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 STUDY OBJECTIVES
- 1.2 MARKET DEFINITION
- 1.3 STUDY SCOPE
- 1.3.1 MARKET SEGMENTATION & GEOGRAPHIC SPREAD
- 1.3.2 INCLUSIONS & EXCLUSIONS
- 1.4 YEARS CONSIDERED
- 1.5 CURRENCY CONSIDERED
- 1.6 STAKEHOLDERS
- 1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
- 2.1 RESEARCH DATA
- 2.1.1 SECONDARY DATA
- 2.1.1.1 Key data from secondary sources
- 2.1.2 PRIMARY DATA
- 2.1.2.1 Key data from primary sources
- 2.1.2.2 Key industry insights
- 2.1.1 SECONDARY DATA
- 2.2 MARKET SIZE ESTIMATION
- 2.3 ASSESSMENT OF MARKET SEGMENTS
- 2.4 ASSESSMENT OF GEOGRAPHIC SEGMENTS
- 2.5 MARKET BREAKDOWN & DATA TRIANGULATION
- 2.6 RESEARCH ASSUMPTIONS
- 2.7 RESEARCH LIMITATIONS
- 2.7.1 METHODOLOGY-RELATED LIMITATIONS
- 2.7.2 SCOPE-RELATED LIMITATIONS
- 2.8 RISK ASSESSMENT
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
- 4.1 OPPORTUNITIES FOR PLAYERS IN BIOPSY DEVICES MARKET
- 4.2 NORTH AMERICA: BIOPSY DEVICES MARKET, BY END USER
- 4.3 BIOPSY DEVICES MARKET: GEOGRAPHIC SNAPSHOT
- 4.4 BIOPSY DEVICES MARKET: GEOGRAPHIC MIX
- 4.5 BIOPSY DEVICES MARKET: DEVELOPING VS. DEVELOPED MARKETS, 2024 VS. 2030 (USD MILLION)
5 MARKET OVERVIEW
- 5.1 INTRODUCTION
- 5.2 MARKET DYNAMICS
- 5.2.1 DRIVERS
- 5.2.1.1 Rising prevalence of cancer
- 5.2.1.2 Increasing preference for minimally invasive surgeries
- 5.2.1.3 Initiatives undertaken by governments and global health organizations
- 5.2.1.4 Increased number of hospitals and diagnostic centers
- 5.2.1.5 Improved reimbursement policies
- 5.2.2 RESTRAINTS
- 5.2.2.1 Increasing product recalls
- 5.2.2.2 High risk of infections
- 5.2.3 OPPORTUNITIES
- 5.2.3.1 Technological advancements
- 5.2.3.2 Growing investments in emerging economies
- 5.2.4 CHALLENGES
- 5.2.4.1 Underdeveloped healthcare infrastructure in emerging economies
- 5.2.1 DRIVERS
- 5.3 INDUSTRY TRENDS
- 5.3.1 MINIMALLY INVASIVE PROCEDURES
- 5.3.2 ROBOTIC-ASSISTED BIOPSY DEVICES
- 5.3.3 LIQUID BIOPSY TECHNOLOGY
- 5.4 TECHNOLOGY ANALYSIS
- 5.4.1 KEY TECHNOLOGIES
- 5.4.1.1 Robotic-assisted biopsy devices
- 5.4.1.2 Optical biopsy technologies
- 5.4.1.3 Minimally invasive biopsy devices
- 5.4.2 COMPLEMENTARY TECHNOLOGIES
- 5.4.2.1 Imaging technologies
- 5.4.2.2 Tissue analysis technologies
- 5.4.2.3 Artificial intelligence
- 5.4.3 ADJACENT TECHNOLOGIES
- 5.4.3.1 Digital pathology and AI integration
- 5.4.3.2 Precision medicine tools
- 5.4.3.3 Advanced needle and probe technologies
- 5.4.1 KEY TECHNOLOGIES
- 5.5 PORTER'S FIVE FORCES ANALYSIS
- 5.5.1 THREAT FROM NEW ENTRANTS
- 5.5.2 BARGAINING POWER OF SUPPLIERS
- 5.5.3 BARGAINING POWER OF BUYERS
- 5.5.4 THREAT FROM SUBSTITUTES
- 5.5.5 INTENSITY OF COMPETITIVE RIVALRY
- 5.6 REGULATORY LANDSCAPE
- 5.6.1 REGULATIONS, BY REGION
- 5.6.1.1 North America
- 5.6.1.1.1 US
- 5.6.1.1.2 Canada
- 5.6.1.2 Europe
- 5.6.1.3 Asia Pacific
- 5.6.1.4 Latin America
- 5.6.1.5 Middle East & Africa
- 5.6.1.1 North America
- 5.6.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 5.6.1 REGULATIONS, BY REGION
- 5.7 PATENT ANALYSIS
- 5.7.1 PATENT PUBLICATION TRENDS IN BIOPSY DEVICES MARKET
- 5.7.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
- 5.8 TRADE ANALYSIS
- 5.9 PRICING ANALYSIS
- 5.9.1 AVERAGE SELLING PRICE OF KEY PLAYERS, BY KEY PRODUCT
- 5.9.2 AVERAGE SELLING PRICE TREND OF BIOPSY DEVICES, BY REGION
- 5.10 KEY CONFERENCES & EVENTS
- 5.11 KEY STAKEHOLDERS & BUYING CRITERIA
- 5.11.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 5.11.2 BUYING CRITERIA
- 5.12 BIOPSY DEVICES MARKET: UNMET NEEDS/EXPECTATIONS OF END USERS
- 5.13 ECOSYSTEM ANALYSIS
- 5.14 CASE STUDY ANALYSIS
- 5.14.1 CASE STUDY 1: DEVICELAB COLLABORATED WITH CLINICAL EXPERTS TO IDENTIFY LIMITATIONS OF EXISTING BREAST BIOPSY PROCEDURES
- 5.14.2 CASE STUDY 2: RESEARCHERS AT UNIVERSITY OF TWENTE DESIGNED ROBOTIC SETUP AND SOFTWARE ARCHITECTURE TO ASSIST RADIOLOGISTS IN TARGETING MRI-DETECTED SUSPICIOUS TUMORS
- 5.14.3 CASE STUDY 3: RESEARCH TEAM DESIGNED FLEXIBLE ROBOTIC SYSTEM FOR BIOPSY SAMPLING APPLIED TO HUMAN CORPSES PLACED INSIDE PROTECTIVE BODY BAGS
- 5.15 SUPPLY CHAIN ANALYSIS
- 5.16 ADJACENT MARKET ANALYSIS
- 5.16.1 BREAST BIOPSY DEVICES MARKET
- 5.17 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
- 5.18 INVESTMENT & FUNDING SCENARIO
- 5.19 IMPACT OF AI ON BIOPSY DEVICES MARKET
6 BIOPSY DEVICES MARKET, BY PRODUCT
- 6.1 INTRODUCTION
- 6.2 NEEDLE-BASED BIOPSY INSTRUMENT
- 6.2.1 CORE NEEDLE BIOPSY
- 6.2.1.1 Core needle biopsy device
- 6.2.1.1.1 Semi-automatic
- 6.2.1.1.1.1 Need for balance of user control and automated functionality in procedures to drive market
- 6.2.1.1.2 Automatic
- 6.2.1.1.2.1 Demand for efficiency and accuracy in biopsy procedures to boost growth
- 6.2.1.1.1 Semi-automatic
- 6.2.1.2 Core needle biopsy needle
- 6.2.1.2.1 Disposable
- 6.2.1.2.1.1 Need for infection control and safety concerns to boost growth
- 6.2.1.2.2 Reusable
- 6.2.1.2.2.1 Cost-effectiveness of reusable core biopsy needles to drive market
- 6.2.1.2.1 Disposable
- 6.2.1.1 Core needle biopsy device
- 6.2.2 FINE NEEDLE ASPIRATION BIOPSY
- 6.2.2.1 Innovations in needle design, including thinner profiles and improved tip configurations, to drive market
- 6.2.3 VACUUM-ASSISTED BIOPSY
- 6.2.3.1 Increasing need for early and accurate cancer detection to drive market
- 6.2.1 CORE NEEDLE BIOPSY
- 6.3 VISUALIZATION DEVICE/SYSTEM
- 6.3.1 RISING PREVALENCE OF CANCER AND OTHER CHRONIC CONDITIONS TO DRIVE DEMAND FOR VISUALIZATION DEVICE
- 6.4 BRUSH BIOPSY INSTRUMENT
- 6.4.1 PREFERENCE FOR MINIMALLY INVASIVE BIOPSY PROCEDURES TO BOOST MARKET
- 6.5 BIOPSY ACCESSORY
- 6.5.1 BIOPSY FORECEP
- 6.5.1.1 General biopsy forcep
- 6.5.1.1.1 Demand for minimally invasive procedures and precise diagnostics to surge growth
- 6.5.1.2 Hot biopsy forecep
- 6.5.1.2.1 Unique ability of hot biopsy forecep to cut and coagulate tissue to support growth
- 6.5.1.1 General biopsy forcep
- 6.5.2 TISSUE MARKER
- 6.5.2.1 Rising cases of breast cancer to boost market growth
- 6.5.3 LOCALIZATION WIRE
- 6.5.3.1 Ability of localization wire to detect precise target locations to drive growth
- 6.5.4 OTHER ACCESSORIES
- 6.5.1 BIOPSY FORECEP
- 6.6 ROBOTIC BIOPSY DEVICE
- 6.6.1 RAPID DEVELOPMENT OF ROBOTIC BIOPSY DEVICES TO BOOST GROWTH
7 BIOPSY DEVICES MARKET, BY TECHNOLOGY
- 7.1 INTRODUCTION
- 7.2 ULTRASOUND-GUIDED BIOPSY
- 7.2.1 ULTRASOUND GUIDANCE ENHANCES SAFETY, MINIMIZES COMPLICATIONS, AND IMPROVES DIAGNOSTIC ACCURACY
- 7.3 STEREOTACTIC-GUIDED BIOPSY
- 7.3.1 NEED FOR EFFICIENT AND ACCURATE BIOPSY PROCEDURES TO SUPPORT MARKET GROWTH
- 7.4 OTHER TECHNOLOGIES
8 BIOPSY DEVICES MARKET, BY APPLICATION
- 8.1 INTRODUCTION
- 8.2 ONCOLOGY
- 8.2.1 BREAST CANCER
- 8.2.1.1 Increasing demand for early and accurate diagnosis to boost growth
- 8.2.2 SOFT TISSUE CANCER
- 8.2.2.1 Advancements in diagnostics and growing emphasis on cancer therapeutics to drive market
- 8.2.1 BREAST CANCER
- 8.3 GASTROENTEROLOGY
- 8.3.1 RISING INCIDENCE OF GASTROINTESTINAL DISEASES TO DRIVE MARKET
- 8.4 BONE & BONE MARROW BIOPSY
- 8.4.1 RISING EMPHASIS ON BONE MARROW BIOPSIES TO SUPPORT MARKET GROWTH
- 8.5 OTHER APPLICATIONS
9 BIOPSY DEVICES MARKET, BY END USER
- 9.1 INTRODUCTION
- 9.2 HOSPITALS & BREAST CARE CENTERS
- 9.2.1 DEMAND FOR STATE-OF-THE-ART BIOPSY FACILITIES TO DRIVE MARKET
- 9.3 DIAGNOSTIC IMAGING CENTERS
- 9.3.1 INCREASING NUMBER OF PRIVATE IMAGING CENTERS TO SUPPORT MARKET GROWTH
- 9.4 AMBULATORY SURGICAL CENTERS
- 9.4.1 GROWING FOCUS ON AMBULATORY CARE TO DRIVE MARKET
- 9.5 OTHER END USERS
10 BIOPSY DEVICES MARKET, BY REGION
- 10.1 INTRODUCTION
- 10.2 NORTH AMERICA
- 10.2.1 MACROECONOMIC OUTLOOK
- 10.2.2 US
- 10.2.2.1 Growth in elderly population to drive market
- 10.2.3 CANADA
- 10.2.3.1 Rising government investments to drive growth
- 10.3 EUROPE
- 10.3.1 MACROECONOMIC OUTLOOK
- 10.3.2 GERMANY
- 10.3.2.1 Increasing prevalence of chronic diseases to propel market
- 10.3.3 UK
- 10.3.3.1 Initiatives by government to support market growth
- 10.3.4 FRANCE
- 10.3.4.1 Rising number of diagnostic imaging centers to drive market
- 10.3.5 ITALY
- 10.3.5.1 Availability of reimbursement coverage to support market growth
- 10.3.6 SPAIN
- 10.3.6.1 Increasing focus on cancer research to propel market
- 10.3.7 REST OF EUROPE
- 10.4 ASIA PACIFIC
- 10.4.1 MACROECONOMIC OUTLOOK
- 10.4.2 CHINA
- 10.4.2.1 Rapidly growing geriatric population to propel market
- 10.4.3 JAPAN
- 10.4.3.1 High adoption of advanced technologies to support market growth
- 10.4.4 INDIA
- 10.4.4.1 Rising prevalence of chronic diseases to drive market
- 10.4.5 AUSTRALIA
- 10.4.5.1 Increasing investments in research to provide opportunities for market growth
- 10.4.6 SOUTH KOREA
- 10.4.6.1 Presence of well-developed healthcare systems to propel market
- 10.4.7 REST OF ASIA PACIFIC
- 10.5 LATIN AMERICA
- 10.5.1 MACROECONOMIC OUTLOOK
- 10.5.2 BRAZIL
- 10.5.2.1 Favourable demographic conditions to drive market
- 10.5.3 MEXICO
- 10.5.3.1 Increased medical tourism and better government healthcare initiatives to drive market
- 10.5.4 REST OF LATIN AMERICA
- 10.6 MIDDLE EAST & AFRICA
- 10.6.1 MACROECONOMIC OUTLOOK
- 10.6.2 GCC COUNTRIES
- 10.6.2.1 Expansion of healthcare providers to drive growth
- 10.6.3 REST OF MIDDLE EAST & AFRICA
11 COMPETITIVE LANDSCAPE
- 11.1 OVERVIEW
- 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
- 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN BIOPSY DEVICES MARKET
- 11.3 REVENUE ANALYSIS
- 11.4 MARKET SHARE ANALYSIS
- 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
- 11.5.1 STARS
- 11.5.2 EMERGING LEADERS
- 11.5.3 PERVASIVE PLAYERS
- 11.5.4 PARTICIPANTS
- 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
- 11.5.5.1 Company footprint
- 11.5.5.2 Region footprint
- 11.5.5.3 Product footprint
- 11.5.5.4 Technology footprint
- 11.5.5.5 Application footprint
- 11.5.5.6 End user footprint
- 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
- 11.6.1 PROGRESSIVE COMPANIES
- 11.6.2 RESPONSIVE COMPANIES
- 11.6.3 DYNAMIC COMPANIES
- 11.6.4 STARTING BLOCKS
- 11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
- 11.7 COMPANY VALUATION & FINANCIAL METRICS
- 11.7.1 COMPANY VALUATION
- 11.7.2 FINANCIAL METRICS
- 11.8 BRAND/PRODUCT COMPARISON
- 11.9 COMPETITIVE SCENARIO
- 11.9.1 PRODUCT LAUNCHES & APPROVALS
- 11.9.2 DEALS
- 11.9.3 EXPANSIONS
12 COMPANY PROFILES
- 12.1 KEY PLAYERS
- 12.1.1 BD (BECTON, DICKINSON AND COMPANY)
- 12.1.1.1 Business overview
- 12.1.1.2 Products offered
- 12.1.1.3 Recent developments
- 12.1.1.3.1 Deals
- 12.1.1.4 MnM view
- 12.1.1.4.1 Key strengths
- 12.1.1.4.2 Strategic choices
- 12.1.1.4.3 Weaknesses & competitive threats
- 12.1.2 DEVICOR MEDICAL PRODUCTS, INC
- 12.1.2.1 Business overview
- 12.1.2.2 Products offered
- 12.1.2.3 Recent developments
- 12.1.2.3.1 Product launches & approvals
- 12.1.2.4 MnM view
- 12.1.2.4.1 Key strengths
- 12.1.2.4.2 Strategic choices
- 12.1.2.4.3 Weaknesses & competitive threats
- 12.1.3 MEDTRONIC
- 12.1.3.1 Business overview
- 12.1.3.2 Products offered
- 12.1.3.3 MnM view
- 12.1.3.3.1 Key strengths
- 12.1.3.3.2 Strategic choices
- 12.1.3.3.3 Weaknesses & competitive threats
- 12.1.4 CARDINAL HEALTH
- 12.1.4.1 Business overview
- 12.1.4.2 Products offered
- 12.1.4.3 MnM view
- 12.1.4.3.1 Key strengths
- 12.1.4.3.2 Strategic choices
- 12.1.4.3.3 Weaknesses & competitive threats
- 12.1.5 HOLOGIC, INC.
- 12.1.5.1 Business overview
- 12.1.5.2 Products offered
- 12.1.5.3 Recent developments
- 12.1.5.3.1 Deals
- 12.1.5.3.2 Other developments
- 12.1.5.4 MnM view
- 12.1.5.4.1 Key strengths
- 12.1.5.4.2 Strategic choices
- 12.1.5.4.3 Weaknesses & competitive threats
- 12.1.6 B. BRAUN SE
- 12.1.6.1 Business overview
- 12.1.6.2 Products offered
- 12.1.7 OLYMPUS CORPORATION
- 12.1.7.1 Business overview
- 12.1.7.2 Products offered
- 12.1.7.3 Recent developments
- 12.1.7.3.1 Deals
- 12.1.8 BOSTON SCIENTIFIC CORPORATION
- 12.1.8.1 Business overview
- 12.1.8.2 Products offered
- 12.1.9 FUJIFILM CORPORATION
- 12.1.9.1 Business overview
- 12.1.9.2 Products offered
- 12.1.10 STRYKER
- 12.1.10.1 Business overview
- 12.1.10.2 Products offered
- 12.1.11 TELEFLEX INCORPORATED
- 12.1.11.1 Business overview
- 12.1.11.2 Products offered
- 12.1.12 CONMED CORPORATION
- 12.1.12.1 Business overview
- 12.1.12.2 Products offered
- 12.1.13 MERIT MEDICAL SYSTEMS
- 12.1.13.1 Business overview
- 12.1.13.2 Products offered
- 12.1.14 JOHNSON & JOHNSON SERVICES, INC.
- 12.1.14.1 Business overview
- 12.1.14.2 Products offered
- 12.1.15 COOK GROUP
- 12.1.15.1 Business overview
- 12.1.15.2 Products offered
- 12.1.15.3 Recent developments
- 12.1.15.3.1 Product launches & approvals
- 12.1.1 BD (BECTON, DICKINSON AND COMPANY)
- 12.2 OTHER PLAYERS
- 12.2.1 MICROPORT SCIENTIFIC CORPORATION
- 12.2.2 ARGON MEDICAL DEVICES
- 12.2.3 INRAD, INC.
- 12.2.4 SUMMIT MEDICAL LLC
- 12.2.5 TRANSMED7, LLC
- 12.2.6 DR. JAPAN CO., LTD.
- 12.2.7 IZI MEDICAL PRODUCTS
- 12.2.8 PLANMED OY
- 12.2.9 ADVIN HEALTH CARE
- 12.2.10 TRIVITRON HEALTHCARE
13 APPENDIX
- 13.1 DISCUSSION GUIDE
- 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
- 13.3 CUSTOMIZATION OPTIONS
- 13.4 RELATED REPORTS
- 13.5 AUTHOR DETAILS
List of Tables
- TABLE 1 BIOPSY DEVICES MARKET: INCLUSIONS & EXCLUSIONS
- TABLE 2 STANDARD CURRENCY CONVERSION RATE, 2019-2024
- TABLE 3 RESEARCH ASSUMPTIONS
- TABLE 4 PORTER'S FIVE FORCES ANALYSIS
- TABLE 5 BIOPSY DEVICES UNDER FDA'S REGULATION 21 CFR 876.1075
- TABLE 6 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 7 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 8 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 9 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 10 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 11 LIST OF PATENTS IN BIOPSY DEVICES MARKET, 2014-2024
- TABLE 12 IMPORT DATA FOR HS CODE 901831-COMPLIANT PRODUCTS, BY KEY COUNTRY, 2019-2023 (USD MILLION)
- TABLE 13 EXPORT DATA FOR HS CODE 901831-COMPLIANT PRODUCTS, BY KEY COUNTRY, 2019-2023 (USD MILLION)
- TABLE 14 AVERAGE SELLING PRICE OF KEY PLAYERS, BY KEY PRODUCT, 2021-2023 (USD)
- TABLE 15 AVERAGE SELLING PRICE TREND OF BIOPSY DEVICES, BY REGION, 2021-2023 (USD)
- TABLE 16 BIOPSY DEVICES MARKET: KEY CONFERENCES & EVENTS, 2025
- TABLE 17 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY END USERS
- TABLE 18 KEY BUYING CRITERIA FOR KEY END USERS
- TABLE 19 BIOPSY DEVICES MARKET: UNMET NEEDS
- TABLE 20 BIOPSY DEVICES MARKET: EXPECTATIONS OF END USERS
- TABLE 21 BIOPSY DEVICES MARKET, BY PRODUCT, 2021-2023 (USD MILLION)
- TABLE 22 BIOPSY DEVICES MARKET, BY PRODUCT, 2024-2030 (USD MILLION)
- TABLE 23 BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021-2023 (USD MILLION)
- TABLE 24 BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024-2030 (USD MILLION)
- TABLE 25 NEEDLE-BASED BIOPSY INSTRUMENT: BIOPSY DEVICES MARKET, BY COUNTRY/ REGION, 2021-2023 (USD MILLION)
- TABLE 26 NEEDLE-BASED BIOPSY INSTRUMENT: BIOPSY DEVICES MARKET, BY COUNTRY/ REGION, 2024-2030 (USD MILLION)
- TABLE 27 BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021-2023 (USD MILLION)
- TABLE 28 BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024-2030 (USD MILLION)
- TABLE 29 CORE NEEDLE BIOPSY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021-2023 (USD MILLION)
- TABLE 30 CORE NEEDLE BIOPSY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024-2030 (USD MILLION)
- TABLE 31 BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021-2023 (USD MILLION)
- TABLE 32 BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024-2030 (USD MILLION)
- TABLE 33 CORE NEEDLE BIOPSY DEVICE: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021-2023 (USD MILLION)
- TABLE 34 CORE NEEDLE BIOPSY DEVICE: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024-2030 (USD MILLION)
- TABLE 35 SEMI-AUTOMATIC: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021-2023 (USD MILLION)
- TABLE 36 SEMI-AUTOMATIC: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024-2030 (USD MILLION)
- TABLE 37 AUTOMATIC: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021-2023 (USD MILLION)
- TABLE 38 AUTOMATIC: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024-2030 (USD MILLION)
- TABLE 39 BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021-2023 (USD MILLION)
- TABLE 40 BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024-2030 (USD MILLION)
- TABLE 41 CORE NEEDLE BIOPSY NEEDLE: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021-2023 (USD MILLION)
- TABLE 42 CORE NEEDLE BIOPSY NEEDLE: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024-2030 (USD MILLION)
- TABLE 43 DISPOSABLE: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021-2023 (USD MILLION)
- TABLE 44 DISPOSABLE: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024-2030 (USD MILLION)
- TABLE 45 REUSABLE: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021-2023 (USD MILLION)
- TABLE 46 REUSABLE: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024-2030 (USD MILLION)
- TABLE 47 FINE NEEDLE ASPIRATION BIOPSY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021-2023 (USD MILLION)
- TABLE 48 FINE NEEDLE ASPIRATION BIOPSY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024-2030 (USD MILLION)
- TABLE 49 VACUUM-ASSISTED BIOPSY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021-2023 (USD MILLION)
- TABLE 50 VACUUM-ASSISTED BIOPSY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024-2030 (USD MILLION)
- TABLE 51 VISUALIZATION DEVICE/SYSTEM: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021-2023 (USD MILLION)
- TABLE 52 VISUALIZATION DEVICE/SYSTEM: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024-2030 (USD MILLION)
- TABLE 53 BRUSH BIOPSY INSTRUMENT: BIOPSY DEVICES MARKET, BY COUNTRY/ REGION, 2021-2023 (USD MILLION)
- TABLE 54 BRUSH BIOPSY INSTRUMENT: BIOPSY DEVICES MARKET, BY COUNTRY/ REGION, 2024-2030 (USD MILLION)
- TABLE 55 BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021-2023 (USD MILLION)
- TABLE 56 BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024-2030 (USD MILLION)
- TABLE 57 BIOPSY ACCESSORY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021-2023 (USD MILLION)
- TABLE 58 BIOPSY ACCESSORY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024-2030 (USD MILLION)
- TABLE 59 BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021-2023 (USD MILLION)
- TABLE 60 BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024-2030 (USD MILLION)
- TABLE 61 BIOPSY FORECEP: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021-2023 (USD MILLION)
- TABLE 62 BIOPSY FORECEP: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024-2030 (USD MILLION)
- TABLE 63 GENERAL BIOPSY FORECEP: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021-2023 (USD MILLION)
- TABLE 64 GENERAL BIOPSY FORECEP: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024-2030 (USD MILLION)
- TABLE 65 HOT BIOPSY FORECEP: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021-2023 (USD MILLION)
- TABLE 66 HOT BIOPSY FORECEP: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024-2030 (USD MILLION)
- TABLE 67 TISSUE MARKER: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021-2023 (USD MILLION)
- TABLE 68 TISSUE MARKER: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024-2030 (USD MILLION)
- TABLE 69 LOCALIZATION WIRE: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021-2023 (USD MILLION)
- TABLE 70 LOCALIZATION WIRE: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024-2030 (USD MILLION)
- TABLE 71 OTHER ACCESSORIES: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021-2023 (USD MILLION)
- TABLE 72 OTHER ACCESSORIES: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024-2030 (USD MILLION)
- TABLE 73 ROBOTIC BIOPSY DEVICE: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021-2023 (USD MILLION)
- TABLE 74 ROBOTIC BIOPSY DEVICE: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024-2030 (USD MILLION)
- TABLE 75 BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021-2023 (USD MILLION)
- TABLE 76 BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024-2030 (USD MILLION)
- TABLE 77 ULTRASOUND-GUIDED BIOPSY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021-2023 (USD MILLION)
- TABLE 78 ULTRASOUND-GUIDED BIOPSY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024-2030 (USD MILLION)
- TABLE 79 STEREOTACTIC-GUIDED BIOPSY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021-2023 (USD MILLION)
- TABLE 80 STEREOTACTIC-GUIDED BIOPSY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024-2030 (USD MILLION)
- TABLE 81 OTHER TECHNOLOGIES: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021-2023 (USD MILLION)
- TABLE 82 OTHER TECHNOLOGIES: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024-2030 (USD MILLION)
- TABLE 83 BIOPSY DEVICES MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
- TABLE 84 BIOPSY DEVICES MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
- TABLE 85 ONCOLOGY: BIOPSY DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
- TABLE 86 ONCOLOGY: BIOPSY DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
- TABLE 87 ONCOLOGY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021-2023 (USD MILLION)
- TABLE 88 ONCOLOGY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024-2030 (USD MILLION)
- TABLE 89 BREAST CANCER: BIOPSY DEVICES CANCER MARKET, BY COUNTRY/REGION, 2021-2023 (USD MILLION)
- TABLE 90 BREAST CANCER: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024-2030 (USD MILLION)
- TABLE 91 SOFT TISSUE CANCER: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021-2023 (USD MILLION)
- TABLE 92 SOFT TISSUE CANCER: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024-2030 (USD MILLION)
- TABLE 93 GASTROENTEROLOGY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021-2023 (USD MILLION)
- TABLE 94 GASTROENTEROLOGY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024-2030 (USD MILLION)
- TABLE 95 BONE & BONE MARROW: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021-2023 (USD MILLION)
- TABLE 96 BONE & BONE MARROW: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024-2030 (USD MILLION)
- TABLE 97 OTHER APPLICATIONS: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021-2023 (USD MILLION)
- TABLE 98 OTHER APPLICATIONS: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024-2030 (USD MILLION)
- TABLE 99 BIOPSY DEVICES MARKET, BY END USER, 2021-2023 (USD MILLION)
- TABLE 100 BIOPSY DEVICES MARKET, BY END USER, 2024-2030 (USD MILLION)
- TABLE 101 HOSPITALS & BREAST CARE CENTERS: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021-2023 (USD MILLION)
- TABLE 102 HOSPITALS & BREAST CARE CENTERS: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024-2030 (USD MILLION)
- TABLE 103 DIAGNOSTIC IMAGING CENTERS: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021-2023 (USD MILLION)
- TABLE 104 DIAGNOSTIC IMAGING CENTERS: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024-2030 (USD MILLION)
- TABLE 105 AMBULATORY SURGICAL CENTERS: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021-2023 (USD MILLION)
- TABLE 106 AMBULATORY SURGICAL CENTERS: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024-2030 (USD MILLION)
- TABLE 107 OTHER END USERS: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021-2023 (USD MILLION)
- TABLE 108 OTHER END USERS: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024-2030 (USD MILLION)
- TABLE 109 BIOPSY DEVICES MARKET, BY REGION, 2021-2023 (USD MILLION)
- TABLE 110 BIOPSY DEVICES MARKET, BY REGION, 2024-2030 (USD MILLION)
- TABLE 111 BIOPSY DEVICES MARKET, BY PRODUCT, 2021-2030 (THOUSAND UNITS)
- TABLE 112 NORTH AMERICA: BIOPSY DEVICES MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
- TABLE 113 NORTH AMERICA: BIOPSY DEVICES MARKET, BY COUNTRY, 2024-2030 (USD MILLION)
- TABLE 114 NORTH AMERICA: BIOPSY DEVICES MARKET, BY PRODUCT, 2021-2023 (USD MILLION)
- TABLE 115 NORTH AMERICA: BIOPSY DEVICES MARKET, BY PRODUCT, 2024-2030 (USD MILLION)
- TABLE 116 NORTH AMERICA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021-2023 (USD MILLION)
- TABLE 117 NORTH AMERICA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024-2030 (USD MILLION)
- TABLE 118 NORTH AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021-2023 (USD MILLION)
- TABLE 119 NORTH AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024-2030 (USD MILLION)
- TABLE 120 NORTH AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021-2023 (USD MILLION)
- TABLE 121 NORTH AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024-2030 (USD MILLION)
- TABLE 122 NORTH AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021-2023 (USD MILLION)
- TABLE 123 NORTH AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024-2030 (USD MILLION)
- TABLE 124 NORTH AMERICA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021-2023 (USD MILLION)
- TABLE 125 NORTH AMERICA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024-2030 (USD MILLION)
- TABLE 126 NORTH AMERICA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021-2023 (USD MILLION)
- TABLE 127 NORTH AMERICA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024-2030 (USD MILLION)
- TABLE 128 NORTH AMERICA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021-2023 (USD MILLION)
- TABLE 129 NORTH AMERICA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024-2030 (USD MILLION)
- TABLE 130 NORTH AMERICA: BIOPSY DEVICES MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
- TABLE 131 NORTH AMERICA: BIOPSY DEVICES MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
- TABLE 132 NORTH AMERICA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021-2023 (USD MILLION)
- TABLE 133 NORTH AMERICA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024-2030 (USD MILLION)
- TABLE 134 NORTH AMERICA: BIOPSY DEVICES MARKET, BY END USER, 2021-2023 (USD MILLION)
- TABLE 135 NORTH AMERICA: BIOPSY DEVICES MARKET, BY END USER, 2024-2030 (USD MILLION)
- TABLE 136 NORTH AMERICA: BIOPSY DEVICES MARKET, BY PRODUCT, 2021-2030 (THOUSAND UNITS)
- TABLE 137 US: MACRO-INDICATORS IMPACTING MARKET
- TABLE 138 US: BIOPSY DEVICES MARKET, BY PRODUCT, 2021-2023 (USD MILLION)
- TABLE 139 US: BIOPSY DEVICES MARKET, BY PRODUCT, 2024-2030 (USD MILLION)
- TABLE 140 US: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021-2023 (USD MILLION)
- TABLE 141 US: BIOPSY DEVICES MARKET, BY NEEDLE BASED BIOPSY INSTRUMENT, 2024-2030 (USD MILLION)
- TABLE 142 US: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021-2023 (USD MILLION)
- TABLE 143 US: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024-2030 (USD MILLION)
- TABLE 144 US: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021-2023 (USD MILLION)
- TABLE 145 US: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024-2030 (USD MILLION)
- TABLE 146 US: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021-2023 (USD MILLION)
- TABLE 147 US: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024-2030 (USD MILLION)
- TABLE 148 US: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021-2023 (USD MILLION)
- TABLE 149 US: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024-2030 (USD MILLION)
- TABLE 150 US: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021-2023 (USD MILLION)
- TABLE 151 US: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024-2030 (USD MILLION)
- TABLE 152 US: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021-2023 (USD MILLION)
- TABLE 153 US: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024-2030 (USD MILLION)
- TABLE 154 US: BIOPSY DEVICES MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
- TABLE 155 US: BIOPSY DEVICES MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
- TABLE 156 US: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021-2023 (USD MILLION)
- TABLE 157 US: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024-2030 (USD MILLION)
- TABLE 158 US: BIOPSY DEVICES MARKET, BY END USER, 2021-2023 (USD MILLION)
- TABLE 159 US: BIOPSY DEVICES MARKET, BY END USER, 2024-2030 (USD MILLION)
- TABLE 160 CANADA: MACRO-INDICATORS IMPACTING MARKET
- TABLE 161 CANADA: BIOPSY DEVICES MARKET, BY PRODUCT, 2021-2023 (USD MILLION)
- TABLE 162 CANADA: BIOPSY DEVICES MARKET, BY PRODUCT, 2024-2030 (USD MILLION)
- TABLE 163 CANADA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021-2023 (USD MILLION)
- TABLE 164 CANADA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024-2030 (USD MILLION)
- TABLE 165 CANADA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021-2023 (USD MILLION)
- TABLE 166 CANADA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024-2030 (USD MILLION)
- TABLE 167 CANADA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021-2023 (USD MILLION)
- TABLE 168 CANADA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024-2030 (USD MILLION)
- TABLE 169 CANADA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021-2023 (USD MILLION)
- TABLE 170 CANADA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024-2030 (USD MILLION)
- TABLE 171 CANADA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021-2023 (USD MILLION)
- TABLE 172 CANADA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024-2030 (USD MILLION)
- TABLE 173 CANADA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021-2023 (USD MILLION)
- TABLE 174 CANADA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024-2030 (USD MILLION)
- TABLE 175 CANADA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021-2023 (USD MILLION)
- TABLE 176 CANADA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024-2030 (USD MILLION)
- TABLE 177 CANADA: BIOPSY DEVICES MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
- TABLE 178 CANADA: BIOPSY DEVICES MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
- TABLE 179 CANADA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021-2023 (USD MILLION)
- TABLE 180 CANADA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024-2030 (USD MILLION)
- TABLE 181 CANADA: BIOPSY DEVICES MARKET, BY END USER, 2021-2023 (USD MILLION)
- TABLE 182 CANADA: BIOPSY DEVICES MARKET, BY END USER, 2024-2030 (USD MILLION)
- TABLE 183 EUROPE: BIOPSY DEVICES MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
- TABLE 184 EUROPE: BIOPSY DEVICES MARKET, BY COUNTRY, 2024-2030 (USD MILLION)
- TABLE 185 EUROPE: BIOPSY DEVICES MARKET, BY PRODUCT, 2021-2023 (USD MILLION)
- TABLE 186 EUROPE: BIOPSY DEVICES MARKET, BY PRODUCT, 2024-2030 (USD MILLION)
- TABLE 187 EUROPE: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021-2023 (USD MILLION)
- TABLE 188 EUROPE: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024-2030 (USD MILLION)
- TABLE 189 EUROPE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021-2023 (USD MILLION)
- TABLE 190 EUROPE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024-2030 (USD MILLION)
- TABLE 191 EUROPE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021-2023 (USD MILLION)
- TABLE 192 EUROPE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024-2030 (USD MILLION)
- TABLE 193 EUROPE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021-2023 (USD MILLION)
- TABLE 194 EUROPE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024-2030 (USD MILLION)
- TABLE 195 EUROPE: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021-2023 (USD MILLION)
- TABLE 196 EUROPE: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024-2030 (USD MILLION)
- TABLE 197 EUROPE: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021-2023 (USD MILLION)
- TABLE 198 EUROPE: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024-2030 (USD MILLION)
- TABLE 199 EUROPE: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021-2023 (USD MILLION)
- TABLE 200 EUROPE: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024-2030 (USD MILLION)
- TABLE 201 EUROPE: BIOPSY DEVICES MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
- TABLE 202 EUROPE: BIOPSY DEVICES MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
- TABLE 203 EUROPE: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021-2023 (USD MILLION)
- TABLE 204 EUROPE: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024-2030 (USD MILLION)
- TABLE 205 EUROPE: BIOPSY DEVICES MARKET, BY END USER, 2021-2023 (USD MILLION)
- TABLE 206 EUROPE: BIOPSY DEVICES MARKET, BY END USER, 2024-2030 (USD MILLION)
- TABLE 207 EUROPE: BIOPSY DEVICES MARKET, BY PRODUCT, 2021-2030 (THOUSAND UNITS)
- TABLE 208 GERMANY: MACRO-INDICATORS IMPACTING MARKET
- TABLE 209 GERMANY: BIOPSY DEVICES MARKET, BY PRODUCT, 2021-2023 (USD MILLION)
- TABLE 210 GERMANY: BIOPSY DEVICES MARKET, BY PRODUCT, 2024-2030 (USD MILLION)
- TABLE 211 GERMANY: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021-2023 (USD MILLION)
- TABLE 212 GERMANY: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024-2030 (USD MILLION)
- TABLE 213 GERMANY: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021-2023 (USD MILLION)
- TABLE 214 GERMANY: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024-2030 (USD MILLION)
- TABLE 215 GERMANY: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021-2023 (USD MILLION)
- TABLE 216 GERMANY: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024-2030 (USD MILLION)
- TABLE 217 GERMANY: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021-2023 (USD MILLION)
- TABLE 218 GERMANY: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024-2030 (USD MILLION)
- TABLE 219 GERMANY: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021-2023 (USD MILLION)
- TABLE 220 GERMANY: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024-2030 (USD MILLION)
- TABLE 221 GERMANY: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021-2023 (USD MILLION)
- TABLE 222 GERMANY: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024-2030 (USD MILLION)
- TABLE 223 GERMANY: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021-2023 (USD MILLION)
- TABLE 224 GERMANY: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024-2030 (USD MILLION)
- TABLE 225 GERMANY: BIOPSY DEVICES MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
- TABLE 226 GERMANY: BIOPSY DEVICES MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
- TABLE 227 GERMANY: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021-2023 (USD MILLION)
- TABLE 228 GERMANY: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024-2030 (USD MILLION)
- TABLE 229 GERMANY: BIOPSY DEVICES MARKET, BY END USER, 2021-2023 (USD MILLION)
- TABLE 230 GERMANY: BIOPSY DEVICES MARKET, BY END USER, 2024-2030 (USD MILLION)
- TABLE 231 UK: MACRO-INDICATORS IMPACTING MARKET
- TABLE 232 UK: BIOPSY DEVICES MARKET, BY PRODUCT, 2021-2023 (USD MILLION)
- TABLE 233 UK: BIOPSY DEVICES MARKET, BY PRODUCT, 2024-2030 (USD MILLION)
- TABLE 234 UK: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021-2023 (USD MILLION)
- TABLE 235 UK: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024-2030 (USD MILLION)
- TABLE 236 UK: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021-2023 (USD MILLION)
- TABLE 237 UK: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024-2030 (USD MILLION)
- TABLE 238 UK: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021-2023 (USD MILLION)
- TABLE 239 UK: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024-2030 (USD MILLION)
- TABLE 240 UK: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021-2023 (USD MILLION)
- TABLE 241 UK: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024-2030 (USD MILLION)
- TABLE 242 UK: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021-2023 (USD MILLION)
- TABLE 243 UK: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024-2030 (USD MILLION)
- TABLE 244 UK: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021-2023 (USD MILLION)
- TABLE 245 UK: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024-2030 (USD MILLION)
- TABLE 246 UK: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021-2023 (USD MILLION)
- TABLE 247 UK: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024-2030 (USD MILLION)
- TABLE 248 UK: BIOPSY DEVICES MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
- TABLE 249 UK: BIOPSY DEVICES MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
- TABLE 250 UK: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021-2023 (USD MILLION)
- TABLE 251 UK: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024-2030 (USD MILLION)
- TABLE 252 UK: BIOPSY DEVICES MARKET, BY END USER, 2021-2023 (USD MILLION)
- TABLE 253 UK: BIOPSY DEVICES MARKET, BY END USER, 2024-2030 (USD MILLION)
- TABLE 254 FRANCE: MACRO-INDICATORS IMPACTING GROWTH
- TABLE 255 FRANCE: BIOPSY DEVICES MARKET, BY PRODUCT, 2021-2023 (USD MILLION)
- TABLE 256 FRANCE: BIOPSY DEVICES MARKET, BY PRODUCT, 2024-2030 (USD MILLION)
- TABLE 257 FRANCE: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021-2023 (USD MILLION)
- TABLE 258 FRANCE: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024-2030 (USD MILLION)
- TABLE 259 FRANCE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021-2023 (USD MILLION)
- TABLE 260 FRANCE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024-2030 (USD MILLION)
- TABLE 261 FRANCE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021-2023 (USD MILLION)
- TABLE 262 FRANCE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024-2030 (USD MILLION)
- TABLE 263 FRANCE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021-2023 (USD MILLION)
- TABLE 264 FRANCE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024-2030 (USD MILLION)
- TABLE 265 FRANCE: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021-2023 (USD MILLION)
- TABLE 266 FRANCE: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024-2030 (USD MILLION)
- TABLE 267 FRANCE: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021-2023 (USD MILLION)
- TABLE 268 FRANCE: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024-2030 (USD MILLION)
- TABLE 269 FRANCE: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021-2023 (USD MILLION)
- TABLE 270 FRANCE: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024-2030 (USD MILLION)
- TABLE 271 FRANCE: BIOPSY DEVICES MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
- TABLE 272 FRANCE: BIOPSY DEVICES MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
- TABLE 273 FRANCE: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021-2023 (USD MILLION)
- TABLE 274 FRANCE: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024-2030 (USD MILLION)
- TABLE 275 FRANCE: BIOPSY DEVICES MARKET, BY END USER, 2021-2023 (USD MILLION)
- TABLE 276 FRANCE: BIOPSY DEVICES MARKET, BY END USER, 2024-2030 (USD MILLION)
- TABLE 277 ITALY: MACRO-INDICATORS IMPACTING MARKET
- TABLE 278 ITALY: BIOPSY DEVICES MARKET, BY PRODUCT, 2021-2023 (USD MILLION)
- TABLE 279 ITALY: BIOPSY DEVICES MARKET, BY PRODUCT, 2024-2030 (USD MILLION)
- TABLE 280 ITALY: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021-2023 (USD MILLION)
- TABLE 281 ITALY: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024-2030 (USD MILLION)
- TABLE 282 ITALY: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021-2023 (USD MILLION)
- TABLE 283 ITALY: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024-2030 (USD MILLION)
- TABLE 284 ITALY: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021-2023 (USD MILLION)
- TABLE 285 ITALY: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024-2030 (USD MILLION)
- TABLE 286 ITALY: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021-2023 (USD MILLION)
- TABLE 287 ITALY: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024-2030 (USD MILLION)
- TABLE 288 ITALY: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021-2023 (USD MILLION)
- TABLE 289 ITALY: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024-2030 (USD MILLION)
- TABLE 290 ITALY: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021-2023 (USD MILLION)
- TABLE 291 ITALY: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024-2030 (USD MILLION)
- TABLE 292 ITALY: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021-2023 (USD MILLION)
- TABLE 293 ITALY: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024-2030 (USD MILLION)
- TABLE 294 ITALY: BIOPSY DEVICES MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
- TABLE 295 ITALY: BIOPSY DEVICES MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
- TABLE 296 ITALY: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021-2023 (USD MILLION)
- TABLE 297 ITALY: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024-2030 (USD MILLION)
- TABLE 298 ITALY: BIOPSY DEVICES MARKET, BY END USER, 2021-2023 (USD MILLION)
- TABLE 299 ITALY: BIOPSY DEVICES MARKET, BY END USER, 2024-2030 (USD MILLION)
- TABLE 300 SPAIN: MACRO-INDICATORS IMPACTING MARKET
- TABLE 301 SPAIN: BIOPSY DEVICES MARKET, BY PRODUCT, 2021-2023 (USD MILLION)
- TABLE 302 SPAIN: BIOPSY DEVICES MARKET, BY PRODUCT, 2024-2030 (USD MILLION)
- TABLE 303 SPAIN: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021-2023 (USD MILLION)
- TABLE 304 SPAIN: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024-2030 (USD MILLION)
- TABLE 305 SPAIN: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021-2023 (USD MILLION)
- TABLE 306 SPAIN: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024-2030 (USD MILLION)
- TABLE 307 SPAIN: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021-2023 (USD MILLION)
- TABLE 308 SPAIN: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024-2030 (USD MILLION)
- TABLE 309 SPAIN: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021-2023 (USD MILLION)
- TABLE 310 SPAIN: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024-2030 (USD MILLION)
- TABLE 311 SPAIN: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021-2023 (USD MILLION)
- TABLE 312 SPAIN: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024-2030 (USD MILLION)
- TABLE 313 SPAIN: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021-2023 (USD MILLION)
- TABLE 314 SPAIN: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024-2030 (USD MILLION)
- TABLE 315 SPAIN: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021-2023 (USD MILLION)
- TABLE 316 SPAIN: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024-2030 (USD MILLION)
- TABLE 317 SPAIN: BIOPSY DEVICES MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
- TABLE 318 SPAIN: BIOPSY DEVICES MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
- TABLE 319 SPAIN: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021-2023 (USD MILLION)
- TABLE 320 SPAIN: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024-2030 (USD MILLION)
- TABLE 321 SPAIN: BIOPSY DEVICES MARKET, BY END USER, 2021-2023 (USD MILLION)
- TABLE 322 SPAIN: BIOPSY DEVICES MARKET, BY END USER, 2024-2030 (USD MILLION)
- TABLE 323 REST OF EUROPE: BIOPSY DEVICES MARKET, BY PRODUCT, 2021-2023 (USD MILLION)
- TABLE 324 REST OF EUROPE: BIOPSY DEVICES MARKET, BY PRODUCT, 2024-2030 (USD MILLION)
- TABLE 325 REST OF EUROPE: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021-2023 (USD MILLION)
- TABLE 326 REST OF EUROPE: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024-2030 (USD MILLION)
- TABLE 327 REST OF EUROPE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021-2023 (USD MILLION)
- TABLE 328 REST OF EUROPE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024-2030 (USD MILLION)
- TABLE 329 REST OF EUROPE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021-2023 (USD MILLION)
- TABLE 330 REST OF EUROPE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024-2030 (USD MILLION)
- TABLE 331 REST OF EUROPE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021-2023 (USD MILLION)
- TABLE 332 REST OF EUROPE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024-2030 (USD MILLION)
- TABLE 333 REST OF EUROPE: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021-2023 (USD MILLION)
- TABLE 334 REST OF EUROPE: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024-2030 (USD MILLION)
- TABLE 335 REST OF EUROPE: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021-2023 (USD MILLION)
- TABLE 336 REST OF EUROPE: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024-2030 (USD MILLION)
- TABLE 337 REST OF EUROPE: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021-2023 (USD MILLION)
- TABLE 338 REST OF EUROPE: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024-2030 (USD MILLION)
- TABLE 339 REST OF EUROPE: BIOPSY DEVICES MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
- TABLE 340 REST OF EUROPE: BIOPSY DEVICES MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
- TABLE 341 REST OF EUROPE: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021-2023 (USD MILLION)
- TABLE 342 REST OF EUROPE: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024-2030 (USD MILLION)
- TABLE 343 REST OF EUROPE: BIOPSY DEVICES MARKET, BY END USER, 2021-2023 (USD MILLION)
- TABLE 344 REST OF EUROPE: BIOPSY DEVICES MARKET, BY END USER, 2024-2030 (USD MILLION)
- TABLE 345 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
- TABLE 346 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY COUNTRY, 2024-2030 (USD MILLION)
- TABLE 347 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY PRODUCT, 2021-2023 (USD MILLION)
- TABLE 348 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY PRODUCT, 2024-2030 (USD MILLION)
- TABLE 349 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021-2023 (USD MILLION)
- TABLE 350 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024-2030 (USD MILLION)
- TABLE 351 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021-2023 (USD MILLION)
- TABLE 352 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024-2030 (USD MILLION)
- TABLE 353 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021-2023 (USD MILLION)
- TABLE 354 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024-2030 (USD MILLION)
- TABLE 355 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021-2023 (USD MILLION)
- TABLE 356 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024-2030 (USD MILLION)
- TABLE 357 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021-2023 (USD MILLION)
- TABLE 358 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024-2030 (USD MILLION)
- TABLE 359 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021-2023 (USD MILLION)
- TABLE 360 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024-2030 (USD MILLION)
- TABLE 361 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021-2023 (USD MILLION)
- TABLE 362 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024-2030 (USD MILLION)
- TABLE 363 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
- TABLE 364 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
- TABLE 365 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021-2023 (USD MILLION)
- TABLE 366 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024-2030 (USD MILLION)
- TABLE 367 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY END USER, 2021-2023 (USD MILLION)
- TABLE 368 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY END USER, 2024-2030 (USD MILLION)
- TABLE 369 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY PRODUCT, 2021-2030 (THOUSAND UNITS)
- TABLE 370 CHINA: MACRO-INDICATORS IMPACTING MARKET
- TABLE 371 CHINA: BIOPSY DEVICES MARKET, BY PRODUCT, 2021-2023 (USD MILLION)
- TABLE 372 CHINA: BIOPSY DEVICES MARKET, BY PRODUCT, 2024-2030 (USD MILLION)
- TABLE 373 CHINA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021-2023 (USD MILLION)
- TABLE 374 CHINA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024-2030 (USD MILLION)
- TABLE 375 CHINA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021-2023 (USD MILLION)
- TABLE 376 CHINA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024-2030 (USD MILLION)
- TABLE 377 CHINA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021-2023 (USD MILLION)
- TABLE 378 CHINA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024-2030 (USD MILLION)
- TABLE 379 CHINA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021-2023 (USD MILLION)
- TABLE 380 CHINA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024-2030 (USD MILLION)
- TABLE 381 CHINA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021-2023 (USD MILLION)
- TABLE 382 CHINA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024-2030 (USD MILLION)
- TABLE 383 CHINA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021-2023 (USD MILLION)
- TABLE 384 CHINA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024-2030 (USD MILLION)
- TABLE 385 CHINA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021-2023 (USD MILLION)
- TABLE 386 CHINA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024-2030 (USD MILLION)
- TABLE 387 CHINA: BIOPSY DEVICES MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
- TABLE 388 CHINA: BIOPSY DEVICES MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
- TABLE 389 CHINA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021-2023 (USD MILLION)
- TABLE 390 CHINA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024-2030 (USD MILLION)
- TABLE 391 CHINA: BIOPSY DEVICES MARKET, BY END USER, 2021-2023 (USD MILLION)
- TABLE 392 CHINA: BIOPSY DEVICES MARKET, BY END USER, 2024-2030 (USD MILLION)
- TABLE 393 JAPAN: MACRO-INDICATORS IMPACTING MARKET
- TABLE 394 JAPAN: BIOPSY DEVICES MARKET, BY PRODUCT, 2021-2023 (USD MILLION)
- TABLE 395 JAPAN: BIOPSY DEVICES MARKET, BY PRODUCT, 2024-2030 (USD MILLION)
- TABLE 396 JAPAN: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021-2023 (USD MILLION)
- TABLE 397 JAPAN: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024-2030 (USD MILLION)
- TABLE 398 JAPAN: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021-2023 (USD MILLION)
- TABLE 399 JAPAN: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024-2030 (USD MILLION)
- TABLE 400 JAPAN: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021-2023 (USD MILLION)
- TABLE 401 JAPAN: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024-2030 (USD MILLION)
- TABLE 402 JAPAN: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021-2023 (USD MILLION)
- TABLE 403 JAPAN: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024-2030 (USD MILLION)
- TABLE 404 JAPAN: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021-2023 (USD MILLION)
- TABLE 405 JAPAN: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024-2030 (USD MILLION)
- TABLE 406 JAPAN: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021-2023 (USD MILLION)
- TABLE 407 JAPAN: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024-2030 (USD MILLION)
- TABLE 408 JAPAN: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021-2023 (USD MILLION)
- TABLE 409 JAPAN: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024-2030 (USD MILLION)
- TABLE 410 JAPAN: BIOPSY DEVICES MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
- TABLE 411 JAPAN: BIOPSY DEVICES MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
- TABLE 412 JAPAN: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021-2023 (USD MILLION)
- TABLE 413 JAPAN: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024-2030 (USD MILLION)
- TABLE 414 JAPAN: BIOPSY DEVICES MARKET, BY END USER, 2021-2023 (USD MILLION)
- TABLE 415 JAPAN: BIOPSY DEVICES MARKET, BY END USER, 2024-2030 (USD MILLION)
- TABLE 416 INDIA: MACRO-INDICATORS IMPACTING GROWTH
- TABLE 417 INDIA: BIOPSY DEVICES MARKET, BY PRODUCT, 2021-2023 (USD MILLION)
- TABLE 418 INDIA: BIOPSY DEVICES MARKET, BY PRODUCT, 2024-2030 (USD MILLION)
- TABLE 419 INDIA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021-2023 (USD MILLION)
- TABLE 420 INDIA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024-2030 (USD MILLION)
- TABLE 421 INDIA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021-2023 (USD MILLION)
- TABLE 422 INDIA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024-2030 (USD MILLION)
- TABLE 423 INDIA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021-2023 (USD MILLION)
- TABLE 424 INDIA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024-2030 (USD MILLION)
- TABLE 425 INDIA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021-2023 (USD MILLION)
- TABLE 426 INDIA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024-2030 (USD MILLION)
- TABLE 427 INDIA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021-2023 (USD MILLION)
- TABLE 428 INDIA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024-2030 (USD MILLION)
- TABLE 429 INDIA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021-2023 (USD MILLION)
- TABLE 430 INDIA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024-2030 (USD MILLION)
- TABLE 431 INDIA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021-2023 (USD MILLION)
- TABLE 432 INDIA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024-2030 (USD MILLION)
- TABLE 433 INDIA: BIOPSY DEVICES MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
- TABLE 434 INDIA: BIOPSY DEVICES MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
- TABLE 435 INDIA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021-2023 (USD MILLION)
- TABLE 436 INDIA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024-2030 (USD MILLION)
- TABLE 437 INDIA: BIOPSY DEVICES MARKET, BY END USER, 2021-2023 (USD MILLION)
- TABLE 438 INDIA: BIOPSY DEVICES MARKET, BY END USER, 2024-2030 (USD MILLION)
- TABLE 439 AUSTRALIA: MACRO-INDICATORS IMPACTING MARKET
- TABLE 440 AUSTRALIA: BIOPSY DEVICES MARKET, BY PRODUCT, 2021-2023 (USD MILLION)
- TABLE 441 AUSTRALIA: BIOPSY DEVICES MARKET, BY PRODUCT, 2024-2030 (USD MILLION)
- TABLE 442 AUSTRALIA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021-2023 (USD MILLION)
- TABLE 443 AUSTRALIA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024-2030 (USD MILLION)
- TABLE 444 AUSTRALIA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021-2023 (USD MILLION)
- TABLE 445 AUSTRALIA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024-2030 (USD MILLION)
- TABLE 446 AUSTRALIA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021-2023 (USD MILLION)
- TABLE 447 AUSTRALIA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024-2030 (USD MILLION)
- TABLE 448 AUSTRALIA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021-2023 (USD MILLION)
- TABLE 449 AUSTRALIA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024-2030 (USD MILLION)
- TABLE 450 AUSTRALIA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021-2023 (USD MILLION)
- TABLE 451 AUSTRALIA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024-2030 (USD MILLION)
- TABLE 452 AUSTRALIA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021-2023 (USD MILLION)
- TABLE 453 AUSTRALIA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024-2030 (USD MILLION)
- TABLE 454 AUSTRALIA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021-2023 (USD MILLION)
- TABLE 455 AUSTRALIA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024-2030 (USD MILLION)
- TABLE 456 AUSTRALIA: BIOPSY DEVICES MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
- TABLE 457 AUSTRALIA: BIOPSY DEVICES MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
- TABLE 458 AUSTRALIA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021-2023 (USD MILLION)
- TABLE 459 AUSTRALIA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024-2030 (USD MILLION)
- TABLE 460 AUSTRALIA: BIOPSY DEVICES MARKET, BY END USER, 2021-2023 (USD MILLION)
- TABLE 461 AUSTRALIA: BIOPSY DEVICES MARKET, BY END USER, 2024-2030 (USD MILLION)
- TABLE 462 SOUTH KOREA: MACRO-INDICATORS IMPACTING MARKET
- TABLE 463 SOUTH KOREA: BIOPSY DEVICES MARKET, BY PRODUCT, 2021-2023 (USD MILLION)
- TABLE 464 SOUTH KOREA: BIOPSY DEVICES MARKET, BY PRODUCT, 2024-2030 (USD MILLION)
- TABLE 465 SOUTH KOREA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021-2023 (USD MILLION)
- TABLE 466 SOUTH KOREA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024-2030 (USD MILLION)
- TABLE 467 SOUTH KOREA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021-2023 (USD MILLION)
- TABLE 468 SOUTH KOREA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024-2030 (USD MILLION)
- TABLE 469 SOUTH KOREA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021-2023 (USD MILLION)
- TABLE 470 SOUTH KOREA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024-2030 (USD MILLION)
- TABLE 471 SOUTH KOREA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021-2023 (USD MILLION)
- TABLE 472 SOUTH KOREA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024-2030 (USD MILLION)
- TABLE 473 SOUTH KOREA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021-2023 (USD MILLION)
- TABLE 474 SOUTH KOREA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024-2030 (USD MILLION)
- TABLE 475 SOUTH KOREA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021-2023 (USD MILLION)
- TABLE 476 SOUTH KOREA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024-2030 (USD MILLION)
- TABLE 477 SOUTH KOREA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021-2023 (USD MILLION)
- TABLE 478 SOUTH KOREA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024-2030 (USD MILLION)
- TABLE 479 SOUTH KOREA: BIOPSY DEVICES MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
- TABLE 480 SOUTH KOREA: BIOPSY DEVICES MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
- TABLE 481 SOUTH KOREA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021-2023 (USD MILLION)
- TABLE 482 SOUTH KOREA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024-2030 (USD MILLION)
- TABLE 483 SOUTH KOREA: BIOPSY DEVICES MARKET, BY END USER, 2021-2023 (USD MILLION)
- TABLE 484 SOUTH KOREA: BIOPSY DEVICES MARKET, BY END USER, 2024-2030 (USD MILLION)
- TABLE 485 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY PRODUCT, 2021-2023 (USD MILLION)
- TABLE 486 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY PRODUCT, 2024-2030 (USD MILLION)
- TABLE 487 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021-2023 (USD MILLION)
- TABLE 488 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024-2030 (USD MILLION)
- TABLE 489 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021-2023 (USD MILLION)
- TABLE 490 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024-2030 (USD MILLION)
- TABLE 491 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021-2023 (USD MILLION)
- TABLE 492 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024-2030 (USD MILLION)
- TABLE 493 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021-2023 (USD MILLION)
- TABLE 494 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024-2030 (USD MILLION)
- TABLE 495 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021-2023 (USD MILLION)
- TABLE 496 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024-2030 (USD MILLION)
- TABLE 497 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021-2023 (USD MILLION)
- TABLE 498 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024-2030 (USD MILLION)
- TABLE 499 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021-2023 (USD MILLION)
- TABLE 500 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024-2030 (USD MILLION)
- TABLE 501 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
- TABLE 502 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
- TABLE 503 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021-2023 (USD MILLION)
- TABLE 504 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024-2030 (USD MILLION)
- TABLE 505 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY END USER, 2021-2023 (USD MILLION)
- TABLE 506 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY END USER, 2024-2030 (USD MILLION)
- TABLE 507 LATIN AMERICA: BIOPSY DEVICES MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
- TABLE 508 LATIN AMERICA: BIOPSY DEVICES MARKET, BY COUNTRY, 2024-2030 (USD MILLION)
- TABLE 509 LATIN AMERICA: BIOPSY DEVICES MARKET, BY PRODUCT, 2021-2023 (USD MILLION)
- TABLE 510 LATIN AMERICA: BIOPSY DEVICES MARKET, BY PRODUCT, 2024-2030 (USD MILLION)
- TABLE 511 LATIN AMERICA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021-2023 (USD MILLION)
- TABLE 512 LATIN AMERICA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024-2030 (USD MILLION)
- TABLE 513 LATIN AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021-2023 (USD MILLION)
- TABLE 514 LATIN AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024-2030 (USD MILLION)
- TABLE 515 LATIN AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021-2023 (USD MILLION)
- TABLE 516 LATIN AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024-2030 (USD MILLION)
- TABLE 517 LATIN AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021-2023 (USD MILLION)
- TABLE 518 LATIN AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024-2030 (USD MILLION)
- TABLE 519 LATIN AMERICA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021-2023 (USD MILLION)
- TABLE 520 LATIN AMERICA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024-2030 (USD MILLION)
- TABLE 521 LATIN AMERICA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021-2023 (USD MILLION)
- TABLE 522 LATIN AMERICA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024-2030 (USD MILLION)
- TABLE 523 LATIN AMERICA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021-2023 (USD MILLION)
- TABLE 524 LATIN AMERICA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024-2030 (USD MILLION)
- TABLE 525 LATIN AMERICA: BIOPSY DEVICES MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
- TABLE 526 LATIN AMERICA: BIOPSY DEVICES MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
- TABLE 527 LATIN AMERICA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021-2023 (USD MILLION)
- TABLE 528 LATIN AMERICA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024-2030 (USD MILLION)
- TABLE 529 LATIN AMERICA: BIOPSY DEVICES MARKET, BY END USER, 2021-2023 (USD MILLION)
- TABLE 530 LATIN AMERICA: BIOPSY DEVICES MARKET, BY END USER, 2024-2030 (USD MILLION)
- TABLE 531 LATIN AMERICA: BIOPSY DEVICES MARKET, BY PRODUCT, 2021-2030 (THOUSAND UNITS)
- TABLE 532 BRAZIL: MACRO-INDICATORS IMPACTING MARKET
- TABLE 533 BRAZIL: BIOPSY DEVICES MARKET, BY PRODUCT, 2021-2023 (USD MILLION)
- TABLE 534 BRAZIL: BIOPSY DEVICES MARKET, BY PRODUCT, 2024-2030 (USD MILLION)
- TABLE 535 BRAZIL: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021-2023 (USD MILLION)
- TABLE 536 BRAZIL: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024-2030 (USD MILLION)
- TABLE 537 BRAZIL: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021-2023 (USD MILLION)
- TABLE 538 BRAZIL: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024-2030 (USD MILLION)
- TABLE 539 BRAZIL: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021-2023 (USD MILLION)
- TABLE 540 BRAZIL: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024-2030 (USD MILLION)
- TABLE 541 BRAZIL: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021-2023 (USD MILLION)
- TABLE 542 BRAZIL: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024-2030 (USD MILLION)
- TABLE 543 BRAZIL: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021-2023 (USD MILLION)
- TABLE 544 BRAZIL: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024-2030 (USD MILLION)
- TABLE 545 BRAZIL: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021-2023 (USD MILLION)
- TABLE 546 BRAZIL: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024-2030 (USD MILLION)
- TABLE 547 BRAZIL: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021-2023 (USD MILLION)
- TABLE 548 BRAZIL: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024-2030 (USD MILLION)
- TABLE 549 BRAZIL: BIOPSY DEVICES MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
- TABLE 550 BRAZIL: BIOPSY DEVICES MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
- TABLE 551 BRAZIL: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021-2023 (USD MILLION)
- TABLE 552 BRAZIL: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024-2030 (USD MILLION)
- TABLE 553 BRAZIL: BIOPSY DEVICES MARKET, BY END USER, 2021-2023 (USD MILLION)
- TABLE 554 BRAZIL: BIOPSY DEVICES MARKET, BY END USER, 2024-2030 (USD MILLION)
- TABLE 555 MEXICO: MACRO-INDICATORS IMPACTING MARKET
- TABLE 556 MEXICO: BIOPSY DEVICES MARKET, BY PRODUCT, 2021-2023 (USD MILLION)
- TABLE 557 MEXICO: BIOPSY DEVICES MARKET, BY PRODUCT, 2024-2030 (USD MILLION)
- TABLE 558 MEXICO: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021-2023 (USD MILLION)
- TABLE 559 MEXICO: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024-2030 (USD MILLION)
- TABLE 560 MEXICO: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021-2023 (USD MILLION)
- TABLE 561 MEXICO: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024-2030 (USD MILLION)
- TABLE 562 MEXICO: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021-2023 (USD MILLION)
- TABLE 563 MEXICO: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024-2030 (USD MILLION)
- TABLE 564 MEXICO: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021-2023 (USD MILLION)
- TABLE 565 MEXICO: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024-2030 (USD MILLION)
- TABLE 566 MEXICO: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021-2023 (USD MILLION)
- TABLE 567 MEXICO: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024-2030 (USD MILLION)
- TABLE 568 MEXICO: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021-2023 (USD MILLION)
- TABLE 569 MEXICO: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024-2030 (USD MILLION)
- TABLE 570 MEXICO: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021-2023 (USD MILLION)
- TABLE 571 MEXICO: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024-2030 (USD MILLION)
- TABLE 572 MEXICO: BIOPSY DEVICES MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
- TABLE 573 MEXICO: BIOPSY DEVICES MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
- TABLE 574 MEXICO: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021-2023 (USD MILLION)
- TABLE 575 MEXICO: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024-2030 (USD MILLION)
- TABLE 576 MEXICO: BIOPSY DEVICES MARKET, BY END USER, 2021-2023 (USD MILLION)
- TABLE 577 MEXICO: BIOPSY DEVICES MARKET, BY END USER, 2024-2030 (USD MILLION)
- TABLE 578 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY PRODUCT, 2021-2023 (USD MILLION)
- TABLE 579 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY PRODUCT, 2024-2030 (USD MILLION)
- TABLE 580 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021-2023 (USD MILLION)
- TABLE 581 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024-2030 (USD MILLION)
- TABLE 582 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021-2023 (USD MILLION)
- TABLE 583 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024-2030 (USD MILLION)
- TABLE 584 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021-2023 (USD MILLION)
- TABLE 585 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024-2030 (USD MILLION)
- TABLE 586 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021-2023 (USD MILLION)
- TABLE 587 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024-2030 (USD MILLION)
- TABLE 588 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021-2023 (USD MILLION)
- TABLE 589 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024-2030 (USD MILLION)
- TABLE 590 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021-2023 (USD MILLION)
- TABLE 591 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024-2030 (USD MILLION)
- TABLE 592 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021-2023 (USD MILLION)
- TABLE 593 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024-2030 (USD MILLION)
- TABLE 594 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
- TABLE 595 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
- TABLE 596 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021-2023 (USD MILLION)
- TABLE 597 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024-2030 (USD MILLION)
- TABLE 598 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY END USER, 2021-2023 (USD MILLION)
- TABLE 599 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY END USER, 2024-2030 (USD MILLION)
- TABLE 600 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
- TABLE 601 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY COUNTRY, 2024-2030 (USD MILLION)
- TABLE 602 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY PRODUCT, 2021-2023 (USD MILLION)
- TABLE 603 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY PRODUCT, 2024-2030 (USD MILLION)
- TABLE 604 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021-2023 (USD MILLION)
- TABLE 605 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024-2030 (USD MILLION)
- TABLE 606 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021-2023 (USD MILLION)
- TABLE 607 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024-2030 (USD MILLION)
- TABLE 608 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021-2023 (USD MILLION)
- TABLE 609 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024-2030 (USD MILLION)
- TABLE 610 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021-2023 (USD MILLION)
- TABLE 611 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024-2030 (USD MILLION)
- TABLE 612 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021-2023 (USD MILLION)
- TABLE 613 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024-2030 (USD MILLION)
- TABLE 614 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021-2023 (USD MILLION)
- TABLE 615 MIDDLE EAST &AFRICA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024-2030 (USD MILLION)
- TABLE 616 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021-2023 (USD MILLION)
- TABLE 617 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024-2030 (USD MILLION)
- TABLE 618 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
- TABLE 619 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
- TABLE 620 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021-2023 (USD MILLION)
- TABLE 621 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024-2030 (USD MILLION)
- TABLE 622 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY END USER, 2021-2023 (USD MILLION)
- TABLE 623 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY END USER, 2024-2030 (USD MILLION)
- TABLE 624 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY PRODUCT, 2021-2030 (THOUSAND UNITS)
- TABLE 625 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY PRODUCT, 2021-2023 (USD MILLION)
- TABLE 626 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY PRODUCT, 2024-2030 (USD MILLION)
- TABLE 627 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021-2023 (USD MILLION)
- TABLE 628 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024-2030 (USD MILLION)
- TABLE 629 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021-2023 (USD MILLION)
- TABLE 630 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024-2030 (USD MILLION)
- TABLE 631 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021-2023 (USD MILLION)
- TABLE 632 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024-2030 (USD MILLION)
- TABLE 633 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021-2023 (USD MILLION)
- TABLE 634 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024-2030 (USD MILLION)
- TABLE 635 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021-2023 (USD MILLION)
- TABLE 636 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024-2030 (USD MILLION)
- TABLE 637 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021-2023 (USD MILLION)
- TABLE 638 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024-2030 (USD MILLION)
- TABLE 639 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021-2023 (USD MILLION)
- TABLE 640 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024-2030 (USD MILLION)
- TABLE 641 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
- TABLE 642 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
- TABLE 643 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021-2023 (USD MILLION)
- TABLE 644 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024-2030 (USD MILLION)
- TABLE 645 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY END USER, 2021-2023 (USD MILLION)
- TABLE 646 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY END USER, 2024-2030 (USD MILLION)
- TABLE 647 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY PRODUCT, 2021-2023 (USD MILLION)
- TABLE 648 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY PRODUCT, 2024-2030 (USD MILLION)
- TABLE 649 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021-2023 (USD MILLION)
- TABLE 650 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024-2030 (USD MILLION)
- TABLE 651 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021-2023 (USD MILLION)
- TABLE 652 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024-2030 (USD MILLION)
- TABLE 653 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021-2023 (USD MILLION)
- TABLE 654 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024-2030 (USD MILLION)
- TABLE 655 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021-2023 (USD MILLION)
- TABLE 656 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024-2030 (USD MILLION)
- TABLE 657 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021-2023 (USD MILLION)
- TABLE 658 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024-2030 (USD MILLION)
- TABLE 659 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021-2023 (USD MILLION)
- TABLE 660 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024-2030 (USD MILLION)
- TABLE 661 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021-2023 (USD MILLION)
- TABLE 662 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024-2030 (USD MILLION)
- TABLE 663 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
- TABLE 664 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
- TABLE 665 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021-2023 (USD MILLION)
- TABLE 666 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024-2030 (USD MILLION)
- TABLE 667 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY END USER, 2021-2023 (USD MILLION)
- TABLE 668 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY END USER, 2024-2030 (USD MILLION)
- TABLE 669 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN BIOPSY DEVICES MARKET
- TABLE 670 BIOPSY DEVICES MARKET: DEGREE OF COMPETITION
- TABLE 671 BIOPSY DEVICES MARKET: REGION FOOTPRINT
- TABLE 672 BIOPSY DEVICES MARKET: PRODUCT FOOTPRINT
- TABLE 673 BIOPSY DEVICES MARKET: TECHNOLOGY FOOTPRINT
- TABLE 674 BIOPSY DEVICES MARKET: APPLICATION FOOTPRINT
- TABLE 675 BIOPSY DEVICES MARKET: END USER FOOTPRINT
- TABLE 676 BIOPSY DEVICES MARKET: DETAILED LIST OF KEY STARTUPS/SMES
- TABLE 677 BIOPSY DEVICES MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS, BY REGION
- TABLE 678 BIOPSY DEVICES MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-JANUARY 2025
- TABLE 679 BIOPSY DEVICES MARKET: DEALS, JANUARY 2021-JANUARY 2025
- TABLE 680 BIOPSY DEVICES MARKET: EXPANSIONS, JANUARY 2021-JANUARY 2025
- TABLE 681 BD (BECTON, DICKINSON AND COMPANY): COMPANY OVERVIEW
- TABLE 682 BD (BECTON, DICKINSON AND COMPANY): PRODUCTS OFFERED
- TABLE 683 BD (BECTON, DICKINSON AND COMPANY): DEALS, JANUARY 2021-JANUARY 2025
- TABLE 684 DEVICOR MEDICAL PRODUCTS, INC: COMPANY OVERVIEW
- TABLE 685 DEVICOR MEDICAL PRODUCTS, INC: PRODUCTS OFFERED
- TABLE 686 DEVICOR MEDICAL PRODUCTS, INC: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-JANUARY 2025
- TABLE 687 MEDTRONIC: COMPANY OVERVIEW
- TABLE 688 MEDTRONIC: PRODUCTS OFFERED
- TABLE 689 CARDINAL HEALTH: COMPANY OVERVIEW
- TABLE 690 CARDINAL HEALTH: PRODUCTS OFFERED
- TABLE 691 HOLOGIC, INC.: COMPANY OVERVIEW
- TABLE 692 HOLOGIC, INC: PRODUCTS OFFERED
- TABLE 693 HOLOGIC, INC: DEALS, JANUARY 2021-JANUARY 2025
- TABLE 694 B. BRAUN SE: COMPANY OVERVIEW
- TABLE 695 B. BRAUN SE: PRODUCTS OFFERED
- TABLE 696 OLYMPUS CORPORATION: COMPANY OVERVIEW
- TABLE 697 OLYMPUS CORPORATION: PRODUCTS OFFERED
- TABLE 698 OLYMPUS CORPORATION: DEALS, JANUARY 2021-JANUARY 2025
- TABLE 699 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW
- TABLE 700 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED
- TABLE 701 FUJIFILM CORPORATION: COMPANY OVERVIEW
- TABLE 702 FUJIFILM CORPORATION: PRODUCTS OFFERED
- TABLE 703 STRYKER: COMPANY OVERVIEW
- TABLE 704 STRYKER: PRODUCTS OFFERED
- TABLE 705 TELEFLEX INCORPORATED: COMPANY OVERVIEW
- TABLE 706 TELEFLEX INCORPORATED: PRODUCTS OFFERED
- TABLE 707 CONMED CORPORATION: COMPANY OVERVIEW
- TABLE 708 CONMED CORPORATION: PRODUCTS OFFERED
- TABLE 709 MERIT MEDICAL SYSTEMS: COMPANY OVERVIEW
- TABLE 710 MERIT MEDICAL SYSTEMS: PRODUCTS OFFERED
- TABLE 711 MERIT MEDICAL SYSTEMS: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-JANUARY 2025
- TABLE 712 MERIT MEDICAL SYSTEMS: DEALS, JANUARY 2021-JANUARY 2025
- TABLE 713 JOHNSON & JOHNSON SERVICES, INC.: COMPANY OVERVIEW
- TABLE 714 JOHNSON & JOHNSON SERVICES INC.: PRODUCTS OFFERED
- TABLE 715 COOK GROUP: COMPANY OVERVIEW
- TABLE 716 COOK GROUP: PRODUCTS OFFERED
- TABLE 717 COOK GROUP: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-JANUARY 2025
List of Figures
- FIGURE 1 RESEARCH DESIGN
- FIGURE 2 PRIMARY SOURCES
- FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
- FIGURE 4 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS
- FIGURE 5 TOP-DOWN APPROACH
- FIGURE 6 IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
- FIGURE 7 BIOPSY DEVICES MARKET: CAGR PROJECTIONS
- FIGURE 8 DATA TRIANGULATION METHODOLOGY
- FIGURE 9 BIOPSY DEVICES MARKET, BY PRODUCT, 2024 VS. 2030 (USD MILLION)
- FIGURE 10 BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024 VS. 2030 (USD MILLION)
- FIGURE 11 BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024 VS. 2030 (USD MILLION)
- FIGURE 12 BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024 VS. 2030 (USD MILLION)
- FIGURE 13 BIOPSY DEVICES MARKET, BY APPLICATION, 2024 VS. 2030 (USD MILLION)
- FIGURE 14 BIOPSY DEVICES MARKET, BY END USER, 2024 VS. 2030 (USD MILLION)
- FIGURE 15 NORTH AMERICA ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
- FIGURE 16 RISING CASES OF CANCER TO DRIVE GLOBAL ADOPTION OF BIOPSY DEVICES
- FIGURE 17 US AND HOSPITALS & BREAST CARE CENTERS SEGMENT ACCOUNTED FOR SIGNIFICANT SHARE IN 2023
- FIGURE 18 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
- FIGURE 19 ASIA PACIFIC TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
- FIGURE 20 DEVELOPING MARKET SEGMENT TO REGISTER HIGHER GROWTH THAN DEVELOPED MARKET SEGMENT BY 2030
- FIGURE 21 BIOPSY DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
- FIGURE 22 TRENDS IN BIOPSY DEVICES MARKET
- FIGURE 23 BIOPSY DEVICES MARKET: PORTER'S FIVE FORCES ANALYSIS
- FIGURE 24 NUMBER OF PATENTS PUBLISHED, 2014-2025
- FIGURE 25 TOP TEN PATENT OWNERS FOR BIOPSY DEVICES, 2014-2025
- FIGURE 26 TOP APPLICANTS FOR BIOPSY DEVICES, 2014-2025
- FIGURE 27 AVERAGE SELLING PRICE OF KEY PLAYERS, BY KEY PRODUCT, 2021-2023 (USD)
- FIGURE 28 AVERAGE SELLING PRICE TREND OF BIOPSY DEVICES, BY REGION, 2021-2023 (USD)
- FIGURE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY END USERS
- FIGURE 30 KEY BUYING CRITERIA FOR KEY END USERS
- FIGURE 31 BIOPSY DEVICES MARKET: ECOSYSTEM ANALYSIS
- FIGURE 32 BIOPSY DEVICES MARKET: SUPPLY CHAIN ANALYSIS
- FIGURE 33 REVENUE SHIFT FOR BIOPSY DEVICES MARKET
- FIGURE 34 INVESTMENT & FUNDING SCENARIO, 2019-2023 (USD MILLION)
- FIGURE 35 USE OF AI/GEN AI IN BIOPSY PROCEDURES
- FIGURE 36 NORTH AMERICA: BIOPSY DEVICES MARKET SNAPSHOT
- FIGURE 37 ASIA PACIFIC: BIOPSY DEVICES MARKET SNAPSHOT
- FIGURE 38 REVENUE ANALYSIS OF KEY PLAYERS, 2021-2023 (USD MILLION)
- FIGURE 39 MARKET SHARE ANALYSIS, 2023
- FIGURE 40 RANKING OF KEY PLAYERS IN BIOPSY DEVICES MARKET, 2023
- FIGURE 41 BIOPSY DEVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
- FIGURE 42 BIOPSY DEVICES MARKET: COMPANY FOOTPRINT
- FIGURE 43 BIOPSY DEVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
- FIGURE 44 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
- FIGURE 45 EV/EBITDA OF KEY PLAYERS
- FIGURE 46 BIOPSY DEVICES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
- FIGURE 47 BD (BECTON, DICKINSON AND COMPANY): COMPANY SNAPSHOT (2024)
- FIGURE 48 DEVICOR MEDICAL PRODUCTS, INC: COMPANY SNAPSHOT (2023)
- FIGURE 49 MEDTRONIC: COMPANY SNAPSHOT (2024)
- FIGURE 50 CARDINAL HEALTH: COMPANY SNAPSHOT (2024)
- FIGURE 51 HOLOGIC, INC.: COMPANY SNAPSHOT (2024)
- FIGURE 52 B. BRAUN SE: COMPANY SNAPSHOT (2023)
- FIGURE 53 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2024)
- FIGURE 54 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2023)
- FIGURE 55 FUJIFILM CORPORATION: COMPANY SNAPSHOT (2024)
- FIGURE 56 STRYKER: COMPANY SNAPSHOT (2023)
- FIGURE 57 TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2023)
- FIGURE 58 CONMED CORPORATION: COMPANY SNAPSHOT (2023)
- FIGURE 59 MERIT MEDICAL SYSTEMS: COMPANY SNAPSHOT (2023)
- FIGURE 60 JOHNSON & JOHNSON SERVICES, INC.: COMPANY SNAPSHOT (2023)
02-2729-4219
+886-2-2729-4219
2025 年至 2033 年活體組織切片設備市場報告（按程序類型、產品、應用、引導技術、最終用戶和地區分類）
真空輔助乳房切片設備市場規模、佔有率、成長分析，按產品類型、程序、應用、最終用戶、地區 - 產業預測 2025-2032
切片檢查設備市場規模、佔有率、成長分析、按產品、按引導技術、按應用、按最終用途、按地區：2024-2031年產業預測
切片檢查設備市場：按產品、技術、應用和最終用戶分類 - 全球預測 2025-2030
支氣管內超音波切片檢查設備市場：按產品、應用和最終用戶 - 全球預測 2025-2030
智慧切片檢查設備市場：按應用、最終用戶分類 - 2025-2030 年全球預測
切片檢查設備市場報告：2030 年趨勢、預測與競爭分析
活體組織切片設備市場，按產品類型、按應用、按最終用戶、按技術、按國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測
切片檢查設備市場規模、佔有率、趨勢分析報告：按產品、地區、細分市場預測，2024-2030 年
抽吸組織切片檢查設備市場，按產品、類型、技術、應用和最終用戶分類：2024-2033 年全球機會分析和產業預測
▼